{'fraction_non_alphanumeric': 0.014423076923076924, 'fraction_numerical': 0.014423076923076924, 'mean_word_length': 5.3106060606060606, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Review of an independent audit into the clinical efficacy of VACUTEX.

An independent report was completed and analysed by Pharmaceutical Research Associates International in August 2001 (Pro-Tex, 2001). This company provides a service to carry out independent project work and research studies within the healthcare sector. The project involved 73 tissue viability nurses and 93 patients, whereby the performance of VACUTEX capillary action wound dressing was assessed on both acute and chronic wounds. The audit takes into account the varying cultures across England and Wales and demonstrates this rapid method of comparing previous dressings used on a multitude of wound types, with analysis focusing on the versatility and efficacy of the VACUTEX capillary action wound dressing. This article reviews the findings of the audit.